MERCK & CO., INC. (MRK)
Clinical trial NCT03213041 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2023-07-01 → 2022-03-30 3. primary completion date: 2022-06-01 → 2021-06-01 4. enrollment: 100 → 12 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Low confidence analysis (52%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical